| Outcomes after transcatheter mitral valve replacement according to regurgitation etiology | The annals of thoracic surgery |  | | 2024 | 71 | 0 |
|
| Veno-arterial extracorporeal membrane oxygenation circuit as second vascular access for transcatheter aortic valve replacement | Cardiology Journal |  | | 2024 | 87 | 37 |
|
| Transcatheter Aortic Valve Replacement for Failed Valve Sparing Procedures | JACC. Cardiovascular interventions |  | | 2023 | 9 | 96 |
|
| Procedural simplification of left atrial appendage occlusion using the VersaCross connect system : First in-human experience | Catheterization and cardiovascular interventions |  | | 2023 | 80 | 0 |
|
| Novel humanized biosimulator to predict coronary obstruction in high-risk valve-in-valve procedures | JACC. Case reports |  | | 2023 | 59 | 48 |
|
| Bicuspid aortic valve stenosis: from pathophysiological mechanism, imaging diagnosis, to clinical treatment methods | Frontiers in cardiovascular medicine |  | | 2022 | 311 | 251 |
|
| Complexity assessment and technical aspect of coronary angiogram and percutaneous coronary intervention following transcatheter aortic valve implantation | Cardiology Journal |  | | 2022 | 192 | 192 |
|
| Large animal models for transcatheter heart valve prosthesis development | JACC. Basic to translational science |  | | 2022 | 58 | 37 |
|
| Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease : A meta-analysis | Journal of thoracic and cardiovascular surgery |  | | 2022 | 72 | 302 |
|
| A novel anatomic classification to guide transcatheter aortic valve replacement for pure aortic regurgitation | Echocardiography |  | | 2022 | 114 | 0 |
|
| Indications, limitations, and development of tricuspid valve interventions in adults | Canadian journal of cardiology |  | | 2022 | 63 | 0 |
|
| Transseptal mitral valve-in-valve implantation in a degenerated mitral bioprosthesis: A case report and literature review | Clinical case reports |  | | 2021 | 167 | 260 |
|
| Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease | Open Heart |  | | 2021 | 255 | 214 |
|
| Five-Year Follow-up After Percutaneous Management of a 40-Year-Old Man in Shock Treated by Percutaneous Coronary Intervention and MitraClip | CJC open |  | | 2020 | 65 | 122 |
|
| Impact of the COVID-19 pandemic on acute coronary syndromes | Swiss Medical Weekly |  | | 2020 | 336 | 181 |
|
| Determinants of hospital length of stay after transcatheter aortic valve implantation with self-expanding prostheses: a prospective, single centre observational study | Swiss medical weekly |  | | 2019 | 101 | 192 |
|
| Conduction disorders using the Evolut R prosthesis compared with the CoreValve: has anything changed? | Open Heart |  | | 2018 | 282 | 172 |
|
| Thirty-day Outcome Following CoreValve Evolut R Transcatheter Aortic Valve Implantation: An All-comers Prospective Study | Revista española de cardiología |  | | 2017 | 540 | 0 |
|
| Paradoxical QRS complex narrowing following transcatheter aortic valve implantation | Cardiovascular Medicine |  | | 2017 | 417 | 334 |
|
| Type A aortic dissection: Are there CT signs suggestive of valvular involvement? | European journal of radiology |  | | 2016 | 593 | 0 |
|
| Management of vascular complications following transcatheter aortic valve implantation | Archives of cardiovascular diseases | | | 2015 | 591 | 0 |
|
| Remplacement valvulaire aortique percutané et complications vasculaires | |  | | 2014 | 891 | 883 |
|